Study shows that a 5:2 intermittent fasting meal replacement diet effectively controls blood glucose levels and reduces body weight in Chinese adults with early type 2 diabetes. This dietary intervention outperforms metformin and empagliflozin in managing diabetes and obesity.
EASD 2023: Effectiveness of GLP-1 Agonists vs. DPP-4Is in Patients with T2D and CKD – Pharmaceutical Technology
Patients with T2D and CKD are limited in their therapeutic use because their low estimated glomerular infiltration rate (eGFR) results in the accumulation of many